Julia M Markov

August 08, 2024 | New York Law Journal

Amid clinicians, researchers and congressional lawmakers urging the FDA to approve MDMA for PTSD despite a negative vote by the FDA's advisory committee, the authors ask: What's next for MDMA?

By Lisa L. Smith, George Hajduczok and Julia M. Markov

12 minute read

January 29, 2024 | New York Law Journal

On Dec. 12, 2023, MAPS PBC, now Lykos Therapeutics, announced their submission of a New Drug Application to the FDA for MDMA in combination with psychotherapy for the treatment of post-traumatic stress disorder.

By Lisa L. Smith, Eric M. Kraus and Julia M. Markov

7 minute read